Biosimilars are medical products, which have undergone patent expiration originally produced by another company. These products can be manufactured when the original products’ patent expires. The market is mainly driven by biosimilars applications related to chronic diseases, whose patent rules have changed. The Global Biosimilars market is expected to grow at a rapid pace during the forecast period due to the emergence of off-patent biologic products. The recombinant non-glycosylated proteins segment is expected to drive the Biosimilars market due to increase in the number of diabetes patients and new versions of insulins.
Europe is expected to have the highest market share because of the arrival of new innovations and patent expiry of biosimilars products in this region. Europe is followed by the APAC region, whose growth is driven by the use of biosimilars products and cost effective treatment for chronic diseases. The North American market is driven by collaborations among key manufacturers. Some of the major players in the market include Amgen Inc., Biocon Ltd., Celltrion Inc., and others.
Infoholic Research’s Global Biosimilars Market report provides detailed information about various market trends and applications covering different segments and regions. The major trends, drivers, restraints and opportunities in each segment are also covered. This study will help stakeholders to understand the current and future market outlook to focus/expand/invest in the Global Biosimilars market.
This report also provides the competitive landscape of the leading players in Global Biosimilars market and this study will help the vendors to understand about their competitor’s landscape. The report can also be tailored as per the specific user requirement. The customization of the report is available based on countries, vendor profiles, enterprise, and vertical wise.
1 Industry Outlook
1.1 Industry Overview
1.2 Industry Trends
1.3 Pest Analysis
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Total Addressable Market (TAM)
3.2 Segmented Addressable Market (SAM)
3.3 Related Markets
4 Market Outlook
4.2 Market Definition – Infoholic Research
4.4 Market Trends
4.5 Importance of Biosimilars Market
4.6 Market Segmentation
4.7 Porter 5(Five) Forces
5 Market Characteristics
5.1 Biosimilars Features
5.2 Biosimilars Advantages
5.3 Biosimilars Scope
5.4 Market Dynamics
5.4.4 DRO – Impact Analysis
5.4.5 Key Stakeholders
6 Product: Market Size and Analysis
6.2 Recombinant Non-glycosylated Proteins
7 Manufacturing: Market Size and Analysis
8 Application: Market Size and Analysis
8.2 Blood Disorders
9 Regions: Market Size and Analysis
10 Market Attractiveness
10.1 Market Attractiveness by Product
10.2 Market Attractiveness by Manufacturing
10.2 Market Attractiveness by Application
10.3 Market Attractiveness by Regions
11 Competitive Landscape
11.2 Vendor Assessment
12 Vendor Profiles
13 Companies to Watch For
14 Global Generalist
Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:
- Data Collation (Primary & Secondary)
- In-house Estimation (Based on proprietary data bases and Models)
- Market Triangulation
Market related information is congregated from both primary and secondary sources.
Primary sources involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.